Takeda Pharmaceuticals is to reduce its global workforce by 10% with the loss of the jobs of 2,100 European employees and 700 US-employees. Most of these jobs will be lost in R&D, commercial, operations and General & Administrative sections.
Within Europe, the German operations of Takeda face a sweeping reorganisation. However, Takeda did not give any other details on the job losses in Europe, apart from stressing that in many countries an overlap exists between the activities of the company and those of Nycomed, the company that Takeda acquired recently.
The internal restructuring process should be fully implemented by the end of 2015.